Molecular Staging and the Selection of Therapy for Non-Small Cell Lung Cancer

被引：2
作者：
D'Amico, Thomas A. [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Thorac Surg, Durham, NC USA
来源：
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY | 2005年 / 17卷 / 03期
关键词：
lung cancer; molecular biology; targeted therapy;
D O I：
10.1053/j.semtcvs.2005.06.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The stage-specific selection of therapy is the standard for patients with non-small cell lung cancer. Investigation of the molecular biology of lung cancer has provided pathways and targets that may be used to improve the efficacy of therapy and improve the survival for patients with lung cancer. © 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：180 / 185
页数：6
相关论文
共 44 条
  • [31] Leighl NB, 2004, J CLIN ONCOL, V22, P7038
  • [32] Revisions in the International System for Staging Lung Cancer
    Mountain, CF
    [J]. CHEST, 1997, 111 (06) : 1710 - 1717
  • [33] Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: The Japanese experience
    Naruke, T
    Tsuchiya, R
    Kondo, H
    Asamura, H
    [J]. ANNALS OF THORACIC SURGERY, 2001, 71 (06) : 1759 - 1764
  • [34] National Comprehensive Cancer Network, 2004, J Natl Compr Canc Netw, V2, P94
  • [35] Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors
    Schlaeppi, JM
    Wood, JM
    [J]. CANCER AND METASTASIS REVIEWS, 1999, 18 (04) : 473 - 481
  • [36] Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer:: Results of a multicenter phase II study
    Schuler, M
    Herrmann, R
    De Greve, JLP
    Stewart, AK
    Gatzemeier, U
    Stewart, DJ
    Laufman, L
    Gralla, R
    Kuball, J
    Buhl, R
    Heussel, CP
    Kommoss, F
    Perruchoud, AP
    Shepherd, FA
    Fritz, MA
    Horowitz, JA
    Huber, C
    Rochlitz, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1750 - 1758
  • [37] Shepherd FA, 2001, P AN M AM SOC CLIN, V20, p4a
  • [38] SHEPHERD FA, 2004, P AM SOC CLIN ONCOL
  • [39] SMYLIE M, 2001, P AN M AM SOC CLIN, V20, pA307
  • [40] STRAUSS G, 2004, P AM SOC CLIN ONCOL
12345